Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease

Geoffrey J. Gorse, Theresa Z. O'Connor, Susan L. Hall, Joseph N. Vitale, Kristin L. Nichol

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Abstract

Background. The clinical features and incidence of human coronavirus (HCoV) infections in chronically ill older adults need better definition. Methods. HCoV infection was determined on the basis of a 4-fold increase in serum antibody and the detection of HCoV by reverse-transcription polymerase chain reaction. Laboratory-documented influenza (LDI) was detected by serologic assay and culture.HCoVillnesses were compared with other acute respiratory illnesses identified by active surveillance, during the 1998-99 winter respiratory-virus season, of 2215 patients with chronic obstructive pulmonary disease who were ≥50 years old and who received influenza vaccines. Results. HCoV-229E and HCoV-OC43 were associated with 90 (14%) of 665 illnesses (HCoV-229E in 22, HCoV-OC43 in 67, and both in 1), LDI with 107 (16%) of 678 illnesses. In multivariate logistic regression analysis, myalgia was less likely with HCoV infection than with LDI (OR, 0.27 [95% confidence limit, 0.13- 0.58]). A majority of these HCoV and LDI illnesses exhibited each of 11 symptoms and signs of acute respiratory illness. Spirometric results worsened most often with LDI, and many acute respiratory illnesses, regardless of etiology, were associated with hospitalization. A total of 8 illnesses were associated with HCoV-NL63, 1 with HCoV-HKU1. Conclusions. The frequencies of HCoV and LDI illnesses were similar. HCoV illness was less severe than LDI illness, was accompanied by multiple respiratory and systemic symptoms, and was associated with hospitalization.

Original languageEnglish (US)
Pages (from-to)847-857
Number of pages11
JournalJournal of Infectious Diseases
Volume199
Issue number6
DOIs
StatePublished - Mar 15 2009

Bibliographical note

Funding Information:
Financial support: Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development (CSP448 and CSP448A to G.J.G., T.Z.O., and J.N.V.); National Institute of Allergy and Infectious Disease, National Institutes of Health (contracts N01-AI-25464, HHSN272200800003C, and N01-AI-80003 to G.J.G.); MedImmune Vaccines, Inc. (formerly Aviron) (funds to the Comparative Studies Program of the Department of Veterans Affairs Office of Research and Development).

Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

Cite this